Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Other Working Capital Changes (2024 - 2025)

Kairos Pharma's Other Working Capital Changes history spans 2 years, with the latest figure at $33000.0 for Q2 2025.

  • For Q2 2025, Other Working Capital Changes rose 1750.0% year-over-year to $33000.0; the TTM value through Jun 2025 reached $71000.0, changed N/A, while the annual FY2025 figure was $13000.0, 56.67% down from the prior year.
  • Other Working Capital Changes reached $33000.0 in Q2 2025 per KAPA's latest filing, up from $17000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $33000.0 in Q2 2025 to a low of -$7000.0 in Q3 2024.